Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.56 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 9/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 3/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27010416 | 0.85 | ALOX5 (0.61) | ALOX5GLRA1MAOBHRH3LMNA | |
| SCHEMBL17833746 | 0.83 | ALOX5 (0.57) | ALOX5GLRA1MAOBHRH3LMNA | |
| SCHEMBL6584399 | 0.82 | ALOX5 (0.53) | ALOX5GLRA1MAOBHRH3LMNA | |
| SCHEMBL1805526 | 0.81 | ALOX5 (0.56) | ALOX5GLRA1MAOBHRH3LMNA | |
| SCHEMBL20705397 | 0.80 | ALOX5 (0.61) | ALOX5MAOBLCKLMNACYP1A2 | |
| SCHEMBL11974257 | 0.79 | MAOB (0.57) | ALOX5GLRA1MAOBHRH3LMNA | |
| SCHEMBL17208245 | 0.79 | ALOX5 (0.57) | ALOX5GLRA1MAOBHRH3LMNA | |
| SCHEMBL683906 | 0.79 | ALOX5 (0.57) | ALOX5GLRA1MAOBHRH3LMNA | |
| SCHEMBL12269234 | 0.79 | ALOX5 (0.56) | ALOX5MAOBHRH3LCKLMNA | |
| SCHEMBL20526940 | 0.78 | ALOX5 (0.56) | ALOX5GLRA1MAOBHRH3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160083327-A1 | GPBP inhibition using Q2 peptidomimetics | JUAN SAUS (ES) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083327-A1 | GPBP inhibition using Q2 peptidomimetics | HSP90B1, ERP44, HSPA5 | ALOX5 4543/4885GLRA1 1278/4885MAOB 4852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.